Targeting hyponitroxia in cancer therapy
Nitric Oxide and Cancer: Pathogenesis and Therapy, Page: 39-48
2015
- 2Citations
- 8Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
It was Oscar Wilde who said "nothing succeeds like excess." Tumors, in particular, subscribe to this creed of greed, avidly consuming glucose, glutamine and lipids while simultaneously overexpressing and stimulating signal transduction pathways in order to accelerate the rate of proliferation and progression. Nitricoxide (NO) is the rare exception to the success of excess in tumors since, in this case, less is more: at low "hyponitroxic" levels NO promotes proliferation while athigh levels NO suppresses it.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84944578772&origin=inward; http://dx.doi.org/10.1007/978-3-319-13611-0_3; https://link.springer.com/10.1007/978-3-319-13611-0_3; https://dx.doi.org/10.1007/978-3-319-13611-0_3; https://link.springer.com/chapter/10.1007/978-3-319-13611-0_3
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know